Literature DB >> 28905940

Bivalirudin for patients with STEMI at high risk of bleeding undergoing PPCI.

Lu Hu1, Kai Guo1, Zhigang Guo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28905940     DOI： 10.1038/nrcardio.2017.141

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

Authors:  Eugenia Nikolsky; Roxana Mehran; George Dangas; Martin Fahy; Yingbo Na; Stuart J Pocock; A Michael Lincoff; Gregg W Stone
Journal:  Eur Heart J       Date:  2007-06-15       Impact factor: 29.983

2.  Bivalirudin started during emergency transport for primary PCI.

Authors:  Philippe Gabriel Steg; Arnoud van 't Hof; Christian W Hamm; Peter Clemmensen; Frédéric Lapostolle; Pierre Coste; Jurrien Ten Berg; Pierre Van Grunsven; Gerrit Jan Eggink; Lutz Nibbe; Uwe Zeymer; Marco Campo dell' Orto; Holger Nef; Jacob Steinmetz; Louis Soulat; Kurt Huber; Efthymios N Deliargyris; Debra Bernstein; Diana Schuette; Jayne Prats; Tim Clayton; Stuart Pocock; Martial Hamon; Patrick Goldstein
Journal:  N Engl J Med       Date:  2013-10-30       Impact factor: 91.245

3.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

4.  Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Authors:  Philip Urban; Ian T Meredith; Alexandre Abizaid; Stuart J Pocock; Didier Carrié; Christoph Naber; Janusz Lipiecki; Gert Richardt; Andres Iñiguez; Philippe Brunel; Mariano Valdes-Chavarri; Philippe Garot; Suneel Talwar; Jacques Berland; Mohamed Abdellaoui; Franz Eberli; Keith Oldroyd; Robaayah Zambahari; John Gregson; Samantha Greene; Hans-Peter Stoll; Marie-Claude Morice
Journal:  N Engl J Med       Date:  2015-10-14       Impact factor: 91.245

5.  Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.

Authors:  Carlo Briguori; Gabriella Visconti; Amelia Focaccio; Michael Donahue; Bruno Golia; Lucio Selvetella; Bruno Ricciardelli
Journal:  JACC Cardiovasc Interv       Date:  2015-02-18       Impact factor: 11.195

Review 6.  Antithrombotic therapy for patients with STEMI undergoing primary PCI.

Authors:  Francesco Franchi; Fabiana Rollini; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

7.  Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

Authors:  Renato D Lopes; Karen P Alexander; Steven V Manoukian; Michel E Bertrand; Frederick Feit; Harvey D White; Charles V Pollack; James Hoekstra; Bernard J Gersh; Gregg W Stone; E Magnus Ohman
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

8.  Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial.

Authors:  Sergio Leonardi; Enrico Frigoli; Martina Rothenbühler; Eliano Navarese; Paolo Calabró; Paolo Bellotti; Carlo Briguori; Marco Ferlini; Bernardo Cortese; Alessandro Lupi; Salvatore Lerna; Dennis Zavallonito-Parenti; Giovanni Esposito; Simone Tresoldi; Antonio Zingarelli; Stefano Rigattieri; Cataldo Palmieri; Armando Liso; Fabio Abate; Marco Zimarino; Marco Comeglio; Gabriele Gabrielli; Alaide Chieffo; Salvatore Brugaletta; Ciro Mauro; Nicolas M Van Mieghem; Dik Heg; Peter Jüni; Stephan Windecker; Marco Valgimigli
Journal:  BMJ       Date:  2016-09-27

9.  Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

Authors:  Adeel Shahzad; Ian Kemp; Christine Mars; Keith Wilson; Claire Roome; Rob Cooper; Mohammed Andron; Clare Appleby; Mike Fisher; Aleem Khand; Babu Kunadian; Joseph D Mills; John L Morris; William L Morrison; Shahzad Munir; Nick D Palmer; Raphael A Perry; David R Ramsdale; Periaswamy Velavan; Rod H Stables
Journal:  Lancet       Date:  2014-07-04       Impact factor: 79.321

10.  Prolonged High-Dose Bivalirudin Infusion Reduces Major Bleeding Without Increasing Stent Thrombosis in Patients Undergoing Primary Percutaneous Coronary Intervention: Novel Insights From an Updated Meta-Analysis.

Authors:  Gregor Fahrni; Mathias Wolfrum; Giovanni Luigi De Maria; Adrian P Banning; Umberto Benedetto; Rajesh K Kharbanda
Journal:  J Am Heart Assoc       Date:  2016-07-22       Impact factor: 5.501
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.